408 results on '"Ledson M"'
Search Results
2. P1.13-04 The LuCID Study: Detection of Lung Cancer Breath Biomarkers via Breath Biopsy in a Multi-Centre Trial
3. EPS1.10 Prevalence, risk factors and outcomes of cardiovascular disease in cystic fibrosis: retrospective cohort study in two large patient data registries
4. WS10.03 Increasing cardiovascular risk in adults with cystic fibrosis related diabetes receiving CFTR modulator therapy (elexacaftor/tezacaftor/ivacaftor)
5. Optimising tissue sampling for the molecular diagnosis of lung adenocarcinoma: P267
6. Early lung cancer team intervention in emergency admissions: P266
7. Survival improves in stage iv lung cancer patients: P260
8. Cfrd is not an independent risk factor for stenotrophomonas maltophilia acquisition - 5 year analysis of uk cf registry data: P248
9. Extended cftr screening for patients with a clinical diagnosis of cf but only one gene on initial screening: P244
10. The liverpool healthy lung project (lhlp) - seeking out lung disease: S12
11. UK Lung Cancer RCT Pilot Screening Trial: baseline findings from the screening arm provide evidence for the potential implementation of lung cancer screening
12. MA05.06 Lung Cancer Screening – Cumulative Results from Five UK-Based Programmes
13. P114 Predicting poor responses to elexacaftor/tezacaftor/ivacaftor: are all responses created equal?
14. Comparison of methods of assessment of renal function in cystic fibrosis (CF) patients
15. S69 Lung cancer screening – cumulative results from five UK-based programmes
16. EPS1.07 Impact of COVID-19 on cystic fibrosis physiotherapy outpatient clinics
17. Fracture and Intra-Cardiac Embolisation of a Totally Implantable Vascular Access Device
18. WHAT IS THE LEVEL OF UNDERSTANDING ABOUT NEBULISER THERAPY IN NURSING STAFF WORKING IN AN ADULT CYSTIC FIBROSIS CENTRE?: 400
19. P309 The use of Dry Powder Mannitol (DPM) – experience at a large adult cystic fibrosis centre
20. S90 Homocystine levels in non-small cell lung cancer
21. Mechanisms of glucose intolerance in cystic fibrosis
22. Transmission of Pseudomonas aeruginosa epidemic strain from a patient with cystic fibrosis to a pet cat
23. THE USE OF ORAL CORTICOSTEROIDS IN CF EXACERBATIONS IN EIRE AND THE UK: 335
24. LATE CEPACIA SYNDROME IN CF PATIENTS COLONIZED BY BURKHOLDERIA CENOCEPACIA: 332
25. ANTIBIOTIC RESISTANCE PATTERNS OF THE MAJOR UK TRANSMISSIBLE PSEUDOMONAS AERUGINOSA STRAIN (LES) AND OTHERS IN ADULT CF PATIENTS IN LIVERPOOL, UK: 329
26. Burkholderia infection and survival in CF
27. Renal Impairment in Cystic Fibrosis Patients Due to Repeated Intravenous Aminoglycoside Use
28. S103 TRANSBRONCHIAL NEEDLE ASPIRATION IN THE UK: A NATIONAL SURVEY
29. S54 INAPPROPRIATE REFERRALS TO THE LUNG CANCER CLINIC
30. S55 ARE RAPID ACCESS LUNG CANCER CLINICS TOO QUICK? THE PATIENT’S VIEW
31. S56 SOCIAL DEPRIVATION AS A RISK FACTOR FOR INPATIENT PRESENTATION WITH LUNG CANCER
32. S35 INCREASED INCIDENCE OF PNEUMOTHORAX IN CYSTIC FIBROSIS PATIENTS COLONISED BY BURKHOLDERIA CENOCEPACIA
33. Increased morbidity associated with chronic infection by an epidemic Pseudomonas aeruginosa strain in CF patients
34. Spread of an epidemic Pseudomonas aeruginosa strain from a patient with cystic fibrosis (CF) to non-CF relatives
35. Outcome of Burkholderia cepacia colonisation in an adult cystic fibrosis centre
36. Respiratory Infections
37. Persistent superior vena caval syndrome due to totally implantable venous access systems
38. Nebulised taurolidine and B cepacia bronchiectasis
39. Epithelioid haemangioendothelioma
40. Novel CFTR corrector FDL169: safety, pharmacokinetics and pharmacodynamics
41. P72 Prevalence and outcomes of unexpected findings in the liverpool healthy lung project (LHLP)
42. P74 Outcome of nodules detected during a healthy lung screening project
43. P2.05-07 The Liverpool "Straight to CT" and "Virtual Working" Lung Cancer Pathway – 5 Years On
44. P1.11-34 The Liverpool Healthy Lung Project – Championing the Importance of Lung Health
45. P1.11-21 Liverpool Health Lung Project: Significant Incidental Findings in a Smoker-Predominant Cohort
46. P1.07-04 Early Lung Cancer Team Intervention in Emergency Admissions
47. OA05.05 Transforming the Patient Experience in Lung Cancer Through the Use of Clinical Nurse Specialist Virtual Clinics - The Liverpool Experience
48. P417 Exploring medication adherence at a large adult cystic fibrosis centre
49. P392 Impact of sino-nasal symptoms on the quality of life in adults with cystic fibrosis
50. P121 Levofloxacin inhaled solution; a retrospective tolerability study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.